Gan H - Search Results

1

Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.

Tamjid B, Phan P, John T, Mitchell P, Gan H. Tamjid B, et al. Among authors: gan h. Head Neck. 2017 Aug;39(8):1544-1549. doi: 10.1002/hed.24751. Epub 2017 Jun 7. Head Neck. 2017. PMID: 28593651

2

A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.

Gan HK, Mitchell PL, Galettis P, Davis ID, Cebon J, de Souza P, Links M. Gan HK, et al. Cancer Chemother Pharmacol. 2006 Aug;58(2):157-64. doi: 10.1007/s00280-005-0152-y. Epub 2005 Nov 19. Cancer Chemother Pharmacol. 2006. PMID: 16328413 Clinical Trial.

3

Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.

Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL. Loveland BE, et al. Among authors: gan h. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):869-77. doi: 10.1158/1078-0432.CCR-05-1574. Clin Cancer Res. 2006. PMID: 16467101 Clinical Trial.

4

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.

Gan HK, Azad A, Cher L, Mitchell PL. Gan HK, et al. Neuro Oncol. 2010 Feb;12(2):212-5. doi: 10.1093/neuonc/nop021. Epub 2009 Dec 24. Neuro Oncol. 2010. PMID: 20150388 Free PMC article.

5

Pretreatment risk stratification of feeding tube use in patients treated with intensity-modulated radiotherapy for head and neck cancer.

Anderson NJ, Jackson JE, Smith JG, Wada M, Schneider M, Poulsen M, Rolfo M, Fahandej M, Gan H, Joon DL, Khoo V. Anderson NJ, et al. Among authors: gan h. Head Neck. 2018 Oct;40(10):2181-2192. doi: 10.1002/hed.25316. Epub 2018 May 13. Head Neck. 2018. PMID: 29756389

6

Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical Trials.

Tiu C, Loh Z, Gan CL, Gan H, John T, Hawkes E. Tiu C, et al. Among authors: gan h, gan cl. Oncology. 2019;97(5):270-276. doi: 10.1159/000501211. Epub 2019 Jul 2. Oncology. 2019. PMID: 31266008

7

The changing landscape of head and neck cancer radiotherapy patients: is high-risk, prolonged feeding tube use indicative of on-treatment weight loss?

Anderson NJ, Jackson JE, Wada M, Schneider M, Poulsen M, Rolfo M, Fahandej M, Gan H, Khoo V. Anderson NJ, et al. Among authors: gan h. J Med Radiat Sci. 2019 Dec;66(4):250-258. doi: 10.1002/jmrs.349. Epub 2019 Aug 6. J Med Radiat Sci. 2019. PMID: 31385650 Free PMC article.

8

Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody-Drug Conjugate.

Anderson MG, Falls HD, Mitten MJ, Oleksijew A, Vaidya KS, Boghaert ER, Gao W, Palma JP, Cao D, Chia PL, John T, Gan HK, Scott AM, Reilly EB. Anderson MG, et al. Mol Cancer Ther. 2020 Oct;19(10):2117-2125. doi: 10.1158/1535-7163.MCT-20-0149. Epub 2020 Aug 26. Mol Cancer Ther. 2020. PMID: 32847977

9

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma.

Chia PL, Parakh S, Tsao MS, Pham NA, Gan HK, Cao D, Burvenich IJG, Rigopoulos A, Reilly EB, John T, Scott AM. Chia PL, et al. Pharmaceuticals (Basel). 2020 Oct 2;13(10):289. doi: 10.3390/ph13100289. Pharmaceuticals (Basel). 2020. PMID: 33023139 Free PMC article.

10

Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.

Chia PL, Parakh S, Russell P, Gan HK, Asadi K, Gebski V, Murone C, Walkiewicz M, Liu Z, Thapa B, Scott FE, Scott AM, John T. Chia PL, et al. Lung Cancer. 2021 Mar;153:35-41. doi: 10.1016/j.lungcan.2020.12.028. Epub 2020 Dec 31. Lung Cancer. 2021. PMID: 33453471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,659 results

Search Page

Filters